182 related articles for article (PubMed ID: 1081925)
1. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus.
Kanra GY; Vesikari T
Clin Exp Immunol; 1975 Jan; 19(1):17-32. PubMed ID: 1204239
[TBL] [Abstract][Full Text] [Related]
3. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
Waldman RH; Ganguly R
Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
[TBL] [Abstract][Full Text] [Related]
4. Brief report. In vitro effects of Rubella virus, strain RA 27/3, on human lymphocytes. III. Inhibition of mitogen stimulation transferred by supernatants from virus-infected cultures.
Maller R; Sörén L
Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):89-91. PubMed ID: 696334
[TBL] [Abstract][Full Text] [Related]
5. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
Rossier E; Phipps PH; Polley JR; Webb T
Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
[TBL] [Abstract][Full Text] [Related]
6. I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors.
Ryzewska AG; Darbrowska BK
Immunology; 1976 Nov; 31(5):677-87. PubMed ID: 136420
[TBL] [Abstract][Full Text] [Related]
7. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection.
Buimovici-Klein E; Lang PB; Ziring PR; Cooper LZ
Pediatrics; 1979 Nov; 64(5):620-6. PubMed ID: 386238
[TBL] [Abstract][Full Text] [Related]
8. Interferon production in lymphocyte cultures after rubella infection in humans.
Buimovici-Klein E; Weiss KE; Cooper LZ
J Infect Dis; 1977 Mar; 135(3):380-5. PubMed ID: 850076
[TBL] [Abstract][Full Text] [Related]
9. Study of the lymphocyte in vitro response to rubella antigen and phytohemagglutinin by a whole blood method.
Buimovici-Klein E; Vesikari T; Santangelo CF; Cooper LZ
Arch Virol; 1976; 52(4):323-31. PubMed ID: 1016065
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.
Jokinen S; Osterlund P; Julkunen I; Davidkin I
J Infect Dis; 2007 Sep; 196(6):861-7. PubMed ID: 17703416
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.
Kramer SL; Granger GA
J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459
[TBL] [Abstract][Full Text] [Related]
12. Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity.
Rola-Pleszczynski M; Hurtado RC; Woody JN; Sell KW; Vincent MM; Hensen SA; Bellanti JA
J Immunol; 1975 Jul; 115(1):239-42. PubMed ID: 50349
[TBL] [Abstract][Full Text] [Related]
13. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
[No Abstract] [Full Text] [Related]
14. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
Santoli D; Trinchieri G; Lief FS
J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
J Infect Dis; 2005 Feb; 191(4):515-9. PubMed ID: 15655774
[TBL] [Abstract][Full Text] [Related]
16. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
Hoppe G
Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
[TBL] [Abstract][Full Text] [Related]
17. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
[TBL] [Abstract][Full Text] [Related]
18. HLA and the rubella-specific immune response following vaccination.
Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lymphocyte stimulation by measles virus.
Sullivan JL; Barry DW; Albrecht P; Lucas SJ
J Immunol; 1975 May; 114(5):1458-61. PubMed ID: 804515
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
Vesikari T; Buimovici-Klein E
Infect Immun; 1975 Apr; 11(4):748-53. PubMed ID: 1120613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
